Overview
Title
To amend the Internal Revenue Code of 1986 to allow an investment credit for certain domestic infant formula manufacturing facilities.
ELI5 AI
H.R. 8971 is a plan that wants to give extra money help to places that make baby formula, like giving them 25 cents back for every dollar they spend on their factory and $1.50 for each pound of formula they make and sell. It's mostly for smaller companies, and there are special rules about who can get this help.
Summary AI
H.R. 8971, also known as the "Investing in New Families And Newborns Through Tax Credit Act" or the "INFANT Tax Credit Act," aims to amend the Internal Revenue Code of 1986. The bill introduces an investment credit for certain domestic infant formula manufacturing facilities, allowing a credit equal to 25% of qualified investments in these facilities. It also establishes a production credit allowing eligible manufacturers to receive $1.50 per pound of infant formula produced and sold in the United States. Additionally, the Secretary of Agriculture is required to submit annual reports to Congress on the number of such facilities receiving funding and the impact they have on their communities.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
Overview of the Bill
The bill, titled the "Investing in New Families And Newborns Through Tax Credit Act" or the "INFANT Tax Credit Act," seeks to amend the Internal Revenue Code of 1986 to introduce tax credits aimed at incentivizing the domestic production of infant formula. The bill establishes two main tax credits: the Domestic Infant Formula Manufacturing Investment Credit and the Infant Formula Production Credit. The former provides a 25% credit on investments in qualified domestic infant formula manufacturing facilities, while the latter offers a $1.50 credit per pound of eligible infant formula produced and sold in the United States. These credits are available to eligible taxpayers based on certain criteria, such as company revenue limits, and include provisions for transferring and electing payment of credits.
Summary of Significant Issues
One primary concern is that the bill appears to favor the infant formula industry by providing specific tax incentives that are not extended to other sectors. Additionally, the eligibility requirements tied to global revenue limits could exclude larger corporations, potentially affecting competition within the industry. The definitions of terms like "qualified property" and "eligible infant formula" are broad, which may lead to different interpretations and potential legal disputes. The bill's coordination rules with existing tax credits introduce complexity, making it more challenging for taxpayers to navigate and comply. The provision allowing for the transfer and elective payment of credits might also lead to financial manipulation. Lastly, the annual reporting requirement to Congress could result in redundant disclosures without yielding significant new insights.
Potential Impact on the Public
Broadly, this bill could encourage the growth of domestic infant formula production, potentially lowering prices and increasing availability for consumers. By incentivizing investments in this sector, the bill might address supply chain issues and create jobs within the United States. However, the exclusion of larger corporations from the tax credits could limit the full potential of these benefits, as larger companies often have the capacity to produce at scale, potentially resulting in lower prices for consumers.
Impact on Specific Stakeholders
For small to medium-sized infant formula manufacturers, the bill presents a significant opportunity. These companies could utilize the tax credits to enhance their production capabilities and competitiveness. However, larger corporations exceeding the revenue cap might view the bill as limiting, potentially lobbying for amendments or different incentives. From a regulatory perspective, administering the credit's provisions could demand additional oversight to ensure compliance and proper interpretation of the tax code. Meanwhile, local communities hosting new manufacturing facilities could see economic growth and increased employment, although the broader industry might experience uneven competition.
Overall, this bill aims to bolster domestic infant formula production, but its impacts could vary across different stakeholders depending on size and capability. Balancing these elements carefully could be crucial in the bill's passage and implementation stages.
Financial Assessment
The bill H.R. 8971, known as the "INFANT Tax Credit Act," proposes significant financial incentives aimed at supporting domestic production of infant formula. These incentives come in the form of tax credits designed to stimulate investment and production within this specific industry.
Investment Credits for Manufacturing Facilities
The bill introduces a 25% investment credit for taxpayers making qualified investments in domestic infant formula manufacturing facilities. The term "qualified investment" encompasses expenditures on tangible property that is essential to the manufacturing operations. This financial incentive is tailored to support smaller and medium-sized companies, as evidenced by the eligibility criteria which limit the benefit to businesses with a total global revenue not exceeding $750,000,000. This limitation may favor these smaller entities over larger corporations, impacting competitive dynamics in the industry, as noted in the issues section.
Production Credits for Infant Formula
Additionally, the bill establishes a production credit that allows qualifying manufacturers to receive $1.50 per pound of eligible infant formula produced and sold within the United States. The qualifications for this credit are geared towards companies with total global revenue not exceeding $500,000,000 in the preceding taxable year. Like the investment credit, this provision seems to favor smaller manufacturers, potentially skewing market competition in favor of these entities over larger conglomerates, which are excluded from benefiting due to the revenue caps.
Coordination and Transfer of Credits
The bill contains provisions allowing for the transfer and elective payment of these tax credits. These mechanisms enable flexibility in how companies can use or monetize their credits, although they may also introduce possibilities for financial manipulation or strategic exploitation. Furthermore, the coordination of these new credits with existing tax provisions adds a layer of complexity, necessitating careful compliance and understanding of related tax code sections. This complexity could burden taxpayers and potentially lead to legal disputes or inconsistent applications, aligning with one of the issues identified earlier.
Potential Industry Bias and Report Requirements
By focusing specifically on infant formula, this bill prioritizes financial benefits for a niche segment of food manufacturing, potentially overlooking other areas of need within the broader industry. Additionally, mandatory annual reports to Congress are required to assess how these facilities impact their local communities and access rural development funds. While necessary for oversight, these reports may become repetitive over time without yielding new insights, as previously highlighted in the issues section.
Overall, the financial aspects of the INFANT Tax Credit Act are poised to drive investment and production within the infant formula industry, yet they also raise questions about fairness, complexity, and market dynamics.
Issues
The bill introduces an investment credit specifically for domestic infant formula manufacturing facilities, potentially favoring this industry and creating an uneven playing field for other food manufacturing industries. This is articulated in Sections 2 and 48F.
The restriction of the investment credit to taxpayers with global revenue not exceeding $750,000,000, and the broader cap of $500,000,000 for the production credit, could exclude larger corporations from the benefits, impacting competition and potentially favoring smaller companies as seen in Sections 2, 3, 48F, and 45BB.
The definitions within the bill, such as 'qualified property' and 'eligible infant formula,' are broad and may lead to various interpretations, raising the risk of legal disputes or inconsistent application. This is evident in Section 48F and Section 3.
The complexity of tax coordination rules, particularly with existing credits and elective payment options, may lead to confusion for taxpayers and require cross-referencing other tax code sections, complicating compliance efforts as noted in Sections 2, 3, 48F, and 45BB.
By allowing credits to be transferable and elective payment options, there might be opportunities for financial manipulation or unintended strategies, which need thorough examination. This issue is present in Sections 2 and 3.
The focus narrowly on infant formula might inadvertently exclude other relevant businesses from potential benefits, which is discussed in Sections 3 and 45BB.
The mandatory annual reports to Congress may lead to redundant reporting obligations without providing significant new insights year-to-year, as stated in Section 4.
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title Read Opens in new tab
Summary AI
The first section of the bill states the short title, indicating that this Act can be referred to as the "Investing in New Families And Newborns Through Tax Credit Act" or the "INFANT Tax Credit Act".
2. Domestic infant formula manufacturing investment credit Read Opens in new tab
Summary AI
The section establishes a tax credit for companies that invest in domestic infant formula manufacturing facilities. This credit allows eligible taxpayers to claim 25% of their investment in qualified properties, such as buildings or equipment integral to the production of infant formula, as long as the formula is made and can be legally sold in the United States, with certain eligibility and revenue criteria for taxpayers.
Money References
- â â(1) IN GENERAL.âFor purposes of this section, the term âeligible taxpayerâ means a taxpayerâ â(A) described in section 48D(c), and â(B) with a total global revenue for the taxable year which does not exceed $750,000,000.
48F. Domestic infant formula manufacturing investment credit Read Opens in new tab
Summary AI
The section introduces a Domestic Infant Formula Manufacturing Investment Credit, which allows eligible taxpayers to receive a credit of 25% on investments made in qualified properties for facilities manufacturing infant formula in the U.S. To qualify, the property must be new to the taxpayer, essential to facility operations, and not used for unrelated functions like offices. Only taxpayers with less than $750 million in global revenue can claim this credit.
Money References
- â (1) IN GENERAL.âFor purposes of this section, the term âeligible taxpayerâ means a taxpayerâ (A) described in section 48D(c), and (B) with a total global revenue for the taxable year which does not exceed $750,000,000. (2) AGGREGATION RULES.âFor purposes of this paragraph, all persons which are treated as a single employer under subsections (a) and (b) of section 52 shall be treated as a single taxpayer. ---
3. Infant formula production credit Read Opens in new tab
Summary AI
The bill introduces a new tax credit called the Infant Formula Production Credit for qualified taxpayers, which provides $1.50 per pound of eligible infant formula they manufacture and sell in the U.S. if their global revenue is under $500 million or if they received this credit the previous year. The credit can be transferred, elected for payment, and is part of the general business credit, applying to formula made after the enactment of this law.
Money References
- (a) In general.âIn the case of a qualified taxpayer, for purposes of section 38, the infant formula production credit for any taxable year is an amount equal to the product ofâ â(1) the amount in pounds of eligible infant formula manufactured by such taxpayer and sold for use in the United States during such taxable year, multiplied by â(2) $1.50. â
- (b) Qualified taxpayer.âFor purposes of this section, the term âqualified taxpayerâ means, with respect to a taxable yearâ â(1) a taxpayer if such taxpayerâs total global revenue for the preceding taxable year does not exceed $500,000,000, or â(2) a taxpayer to whom a credit was allowed under this section in the preceding taxable year.
45BB. Infant formula production credit Read Opens in new tab
Summary AI
The text establishes a tax credit for manufacturers of infant formula. A qualified taxpayer can receive a credit of $1.50 per pound of eligible infant formula produced and sold in the U.S., with eligibility requiring global revenue under $500 million or having received the credit in the previous year; however, production in facilities already receiving certain investment credits is excluded.
Money References
- (a) In general.âIn the case of a qualified taxpayer, for purposes of section 38, the infant formula production credit for any taxable year is an amount equal to the product ofâ (1) the amount in pounds of eligible infant formula manufactured by such taxpayer and sold for use in the United States during such taxable year, multiplied by (2) $1.50. (b) Qualified taxpayer.âFor purposes of this section, the term âqualified taxpayerâ means, with respect to a taxable yearâ (1) a taxpayer if such taxpayerâs total global revenue for the preceding taxable year does not exceed $500,000,000, or (2) a taxpayer to whom a credit was allowed under this section in the preceding taxable year.
4. Reports to Congress Read Opens in new tab
Summary AI
The section requires the Secretary of Agriculture to send a yearly report to Congress about: the number of people running domestic infant formula manufacturing facilities and receiving funding from rural development programs; any barriers preventing these facilities from getting such funding; and the effects these facilities have on their local communities.